Lease of one (1) Molecular Methicillin-Resistant Staphylococcus aureus (MRSA) analyzer
Closed Special Notice Posted
- Solicitation number
- PANHCA-26-P-0000-026886
- Agency
-
Medical Command
Department of the Army, Department of Defense
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- Place of performance
- Fort Bliss, Texas 79918, United States
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of the Army Medical Command issued a sole-source justification notice on July 30, 2026, announcing its intent to award a non-personal service contract to Cepheid for a five-year lease of one Molecular MRSA analyzer at William Beaumont Army Medical Center, Fort Bliss, Texas, with a performance period of October 1, 2026 through September 30, 2031. The base contract runs one year (October 1, 2026–September 30, 2027) with four one-year options exercisable through September 30, 2031.
The analyzer must support testing for MRSA, Influenza, RSV, SARS-CoV-2, Strep A, Mycobacterium Tuberculosis, and Carbapenem detection on a single integrated platform. The contract is funded through Fiscal Year 2027 Defense Health Program funds and includes maintenance, troubleshooting, replacement services, and software support within the lease cost. The justification establishes that Cepheid is the sole vendor capable of meeting requirements due to proprietary firmware and the closed-system analyzer business model standard in the in-vitro diagnostics market. Market research conducted in December 2025 and March 2026 confirmed that the IVD market is highly concentrated with significant barriers to entry, including proprietary technology, stringent FDA regulatory approvals, and closed-system platforms. No unresolved FDA recalls exist for the Cepheid system. All responsible sources may submit a capability statement by August 3, 2026, demonstrating ability to provide a non-personal service lease of a Molecular MRSA analyzer; capability statements will be considered by the agency.
Notice text
On or about 31 July 2026, the Medical Readiness Contracting Officer- West intends to issue a sole source contract to Cepheid for a non-personal service contract for lease of Molecular MRSA analyzer to support William Beaumont Army Medical Center (WBAMC), Fort Bliss, TX. The period of performance is 01 October 2026 to 30 September 2031. This notice is neither a request for quotes nor a solicitation of offers; however, all responsible sources may submit a capability statement, which shall be considered by the agency. The capability statement shall include information of suicient detail to demonstrate that they are able to provide a non-personal service contract for the lease of Molecular MRSA analyzer.
Files
| File | Type | Posted |
|---|---|---|
| Justification FAR Part 12 Molecular MRSA Testing Anazlyzer - Redacted.pdf |
Notice history
| Notice | Type | Posted |
|---|---|---|
| This notice | Special Notice | |
| Molecular MRSA testing analyzer | Pre-Solicitation |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Notice of Award Maintenance for Government owned BacT/ALERT 3D Equipment. | Medical Command | No set-aside | |
| 6550--Cepheid GeneXpert Testing Supplies | Veterans Integrated Service Network 5 | No set-aside | |
| Microbial Identification System (MIS) | Medical Command | No set-aside | |
| 6550--VISN Cepheid GeneXpert Testing Supplies Base Plus 3 Op Yr RFQ | Veterans Integrated Service Network 5 | No set-aside | |
| J065--BELIMED STERILIZERS & WASHERS PM&R - BASE YEAR | SBAR Approved | WD EXEMPT | | Veterans Integrated Service Network 22 | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity